Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -12.77 Million USD | -59.67% |
| 2022 | -5.26 Million USD | -234.65% |
| 2021 | -1.57 Million USD | -27.44% |
| 2020 | -1.23 Million USD | -2489.61% |
| 2019 | -47.71 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -1.59 Million USD | 31.9% |
| 2023 Q1 | -2.34 Million USD | 53.78% |
| 2023 FY | - USD | -59.67% |
| 2023 Q4 | -3.89 Million USD | -83.16% |
| 2023 Q3 | -2.12 Million USD | -33.06% |
| 2022 Q4 | -5.07 Million USD | -451.87% |
| 2022 Q3 | -919.9 Thousand USD | -1238.28% |
| 2022 Q2 | -68.73 Thousand USD | 91.92% |
| 2022 FY | - USD | -234.65% |
| 2022 Q1 | -851.21 Thousand USD | -29.57% |
| 2021 Q1 | -269.51 Thousand USD | -166.44% |
| 2021 FY | - USD | -27.44% |
| 2021 Q4 | -656.97 Thousand USD | -101.06% |
| 2021 Q3 | -326.75 Thousand USD | -1.71% |
| 2021 Q2 | -321.25 Thousand USD | -19.2% |
| 2020 FY | - USD | -2489.61% |
| 2020 Q4 | 405.62 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -150.1 Million USD | 91.491% |
| Theratechnologies Inc. | -10.31 Million USD | -23.858% |
| Safety Shot Inc | -12.18 Million USD | -4.826% |
| Cosmos Health Inc. | -17.06 Million USD | 25.135% |
| Cronos Group Inc. | -72.14 Million USD | 82.296% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 98.619% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 64.599% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 135.451% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -297.294% |
| ProPhase Labs, Inc. | -14.82 Million USD | 13.851% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -182.282% |
| Dynavax Technologies Corporation | 9.66 Million USD | 232.146% |
| Radius Health, Inc. | 38.31 Million USD | 133.342% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -443.31% |
| Alvotech | -484.86 Million USD | 97.366% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -233.992% |
| Alpha Teknova, Inc. | -25.53 Million USD | 49.985% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 91.959% |
| SCYNEXIS, Inc. | 73.47 Million USD | 117.384% |
| Harrow Health, Inc. | 9.72 Million USD | 231.372% |
| Biofrontera Inc. | -18.45 Million USD | 30.779% |
| DURECT Corporation | -24.68 Million USD | 48.253% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 112.999% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 111.684% |
| OptiNose, Inc. | -15.55 Million USD | 17.873% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 148.63% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 1180.649% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -1696.901% |
| SIGA Technologies, Inc. | 84.15 Million USD | 115.177% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 1673.063% |
| Shineco, Inc. | -26.55 Million USD | 51.897% |
| Phibro Animal Health Corporation | 84.6 Million USD | 115.097% |
| Procaps Group S.A. | 104.02 Million USD | 112.279% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -52.045% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -253.084% |
| Viatris Inc. | 3.51 Billion USD | 100.363% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -233.992% |
| Rockwell Medical, Inc. | -4.69 Million USD | -172.119% |
| Incannex Healthcare Limited | -18.5 Million USD | 30.97% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -1162.181% |
| Tilray Brands, Inc. | -72.84 Million USD | 82.465% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 104.143% |
| PetIQ, Inc. | 81.48 Million USD | 115.675% |
| Silver Spike Investment Corp. | 7.34 Million USD | 274.02% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 103.07% |
| Journey Medical Corporation | 1.92 Million USD | 764.928% |
| Alimera Sciences, Inc. | 7.27 Million USD | 275.553% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -203.268% |
| Assertio Holdings, Inc. | -222.44 Million USD | 94.258% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -220.08% |
| Embecta Corp. | 245.4 Million USD | 105.205% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 36.232% |
| Procaps Group, S.A. | 104.02 Million USD | 112.279% |
| PainReform Ltd. | -9.56 Million USD | -33.486% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 91.435% |
| Talphera, Inc. | -9.84 Million USD | -29.783% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 107.841% |
| Alvotech | -484.86 Million USD | 97.366% |
| Lantheus Holdings, Inc. | 491 Million USD | 102.601% |
| Kamada Ltd. | 21.53 Million USD | 159.317% |
| Indivior PLC | 66 Million USD | 119.353% |
| Currenc Group, Inc. | -1.9 Million USD | -572.074% |
| Evoke Pharma, Inc. | -7.29 Million USD | -75.161% |
| Flora Growth Corp. | -45.87 Million USD | 72.153% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 36.232% |
| Evolus, Inc. | -41.81 Million USD | 69.449% |
| HUTCHMED (China) Limited | 25.52 Million USD | 150.036% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 105.29% |
| Akanda Corp. | -27.73 Million USD | 53.946% |